Hoth Net Income vs Enterprise Value Analysis
HOTH Stock | USD 1.18 0.05 4.07% |
Hoth Therapeutics financial indicator trend analysis is much more than just examining Hoth Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hoth Therapeutics is a good investment. Please check the relationship between Hoth Therapeutics Net Income and its Enterprise Value accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Net Income vs Enterprise Value
Net Income vs Enterprise Value Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hoth Therapeutics Net Income account and Enterprise Value. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Hoth Therapeutics' Net Income and Enterprise Value is 0.89. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Hoth Therapeutics, assuming nothing else is changed. The correlation between historical values of Hoth Therapeutics' Net Income and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Hoth Therapeutics are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Net Income i.e., Hoth Therapeutics' Net Income and Enterprise Value go up and down completely randomly.
Correlation Coefficient | 0.89 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Hoth Therapeutics financial statement analysis. It represents the amount of money remaining after all of Hoth Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Enterprise Value
Enterprise Value (or EV) is usually referred to as Hoth Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Hoth Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Hoth Therapeutics value than its market capitalization because it takes into account all of Hoth Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from Hoth Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Selling General Administrative is increasing as compared to previous years. The Hoth Therapeutics' current Enterprise Value Over EBITDA is estimated to increase to 0.59, while Issuance Of Capital Stock is projected to decrease to under 9.4 M.
Hoth Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Other Current Liab | 36.2K | 182.7K | 506.8K | 692.7K | 614.2K | 352.1K | |
Total Current Liabilities | 440.1K | 312.1K | 867.8K | 1.4M | 678.7K | 641.9K | |
Total Stockholder Equity | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Net Tangible Assets | 154.7K | 2.4M | 4.6M | 9.9M | 11.4M | 11.9M | |
Net Debt | (1.7M) | (2.6M) | (8.5M) | (6.4M) | (9.2M) | (8.8M) | |
Retained Earnings | (12.2M) | (19.4M) | (33.7M) | (45.1M) | (52.9M) | (50.3M) | |
Accounts Payable | 403.9K | 129.5K | 361.0K | 695.0K | 35.6K | 33.8K | |
Cash | 1.7M | 2.6M | 8.5M | 6.4M | 9.3M | 4.7M | |
Non Current Assets Total | 201.0K | 460K | 410K | 33K | 92.6K | 87.9K | |
Non Currrent Assets Other | 200K | 50K | 410K | 33K | (1.0) | (0.95) | |
Cash And Short Term Investments | 2.5M | 4.7M | 10.4M | 6.6M | 9.3M | 5.5M | |
Common Stock Shares Outstanding | 366.6K | 494.5K | 893.2K | 1.2M | 3.4M | 1.8M | |
Liabilities And Stockholders Equity | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Non Current Liabilities Total | 403.9K | 285K | 235K | 250K | 26.3K | 25.0K | |
Other Stockholder Equity | 14.6M | 24.1M | 43.6M | 50.2M | 61.7M | 31.8M | |
Total Liab | 440.1K | 597.1K | 1.1M | 1.6M | 705.0K | 767.0K | |
Net Invested Capital | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Total Current Assets | 2.6M | 4.8M | 10.6M | 6.7M | 9.4M | 5.6M | |
Net Working Capital | 2.2M | 4.5M | 9.7M | 5.3M | 8.7M | 5.0M | |
Common Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 413.25 | |
Other Current Assets | 140.6K | 89.8K | 94.0M | 88.5K | 135.4K | 128.6K | |
Capital Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 818.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.